NORA SCHWARTZ-MARTIN: Open Payments
NPI 1093821092 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 16 payments from 4 companies in 2025. Trend: 2023 $647 · 2024 $589 · 2025 $438
Food & beverage: $428Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $294 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, REXULTI, INGREZZA, Auvelity.
Industry payments across MA — which companies pay providers there.
